Modified b cells and methods of use thereof
AssigneeWalking Fish Therapeutics
InventorsKathleen Boyle, Hangil Park, Srinivas Kothakota, Mark Selby, Thomas Brennan, Lewis T. Williams
Life of this patent
Estimating the term…
Loading patent…
AssigneeWalking Fish Therapeutics
InventorsKathleen Boyle, Hangil Park, Srinivas Kothakota, Mark Selby, Thomas Brennan, Lewis T. Williams
Estimating the term…
The present invention relates to genetically modified B cells and their uses thereof, for example, for the treatment of a variety of diseases and disorders, including cancer, heart disease, inflammatory disease, muscle wasting disease, neurological disease, and the like. In certain embodiments, the invention relates to an isolated modified B cell (“CAR-B cell”), capable of expressing a chimeric receptor (“CAR-B receptor”), wherein said chimeric receptor comprises (a) an extracellular domain; (b) a transmembrane domain; and (c) a cytoplasmic domain that comprises at least one signaling domain. In various embodiments, the invention comprises an isolated modified B cell, wherein said B cell is capable of expressing and secreting a payload, wherein the payload is not naturally expressed in a B cell or is expressed at higher levels than is naturally expressed in a B cell. In various embodiments, the payload is an antibody or fragment thereof.
A population of modified B cells engineered to express a payload, wherein the B cells comprise a chimeric antigen receptor comprising
16-27. (canceled)
A method for treating a subject in need thereof, comprising administering to the subject a population of modified B cells engineered to express a payload, wherein the B cells comprise a chimeric antigen receptor comprising
(canceled)
32-40. (canceled)
42-54. (canceled)
A method of making a population of modified B cells engineered to express a payload comprising:
Dependencies are inferred from the claim text.